Outlook Therapeutics prices $55.0 million common stock and warrants offering
Outlook Therapeutics announces the pricing of a $55.0 million public offering of common stock and warrants, selling $55.0 million total under the priced terms.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.